VS
Venkata Satya Kumar Chakravarthy Ravella
About Venkata Satya Kumar Chakravarthy Ravella
Data last updated:
Venkata Satya Kumar Chakravarthy Ravella has 27 years in corporate governance. Holds Director role. Currently with 1 company, including Unique Biotech Limited. Engaged in Technology. Contributes to corporate operations. The largest current company by reported revenue is Unique Biotech Limited at ₹199 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Unique Biotech Limited U24239TG1999PLC031113 | Director | 15 Feb 1999 | 1999 | ₹199 Cr (FY 2024) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Venkata Satya Kumar Chakravarthy Ravella
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Venkata Satya Kumar Chakravarthy Ravella
Venkata Satya Kumar Chakravarthy Ravella has 27 years in corporate governance. Holds Director role. Currently with 1 company, including Unique Biotech Limited. Engaged in Technology. Contributes to corporate operations. The largest current company by reported revenue is Unique Biotech Limited at ₹199 Cr (FY 2024).
Venkata Satya Kumar Chakravarthy Ravella is associated with 1 company as Director, including Unique Biotech Limited (₹199 Cr).
Venkata Satya Kumar Chakravarthy Ravella has expertise in Technology.
Venkata Satya Kumar Chakravarthy Ravella has 27 years in corporate governance.
By reported revenue, the largest current company of Venkata Satya Kumar Chakravarthy Ravella is Unique Biotech Limited, with revenue of ₹199 Cr (FY 2024).
Venkata Satya Kumar Chakravarthy Ravella currently holds positions at 1 company: Unique Biotech Limited (₹199 Cr).